Norinchukin Bank The boosted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 180,773 shares of the healthcare conglomerate’s stock after purchasing an additional 4,838 shares during the quarter. UnitedHealth Group comprises approximately 0.7% of Norinchukin Bank The’s holdings, making the stock its 20th biggest position. Norinchukin Bank The’s holdings in UnitedHealth Group were worth $35,405,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. ING Groep NV grew its position in UnitedHealth Group by 48.0% during the 3rd quarter. ING Groep NV now owns 301,997 shares of the healthcare conglomerate’s stock worth $59,146,000 after purchasing an additional 97,994 shares during the period. D.A. Davidson & CO. grew its position in shares of UnitedHealth Group by 2.5% during the 3rd quarter. D.A. Davidson & CO. now owns 72,007 shares of the healthcare conglomerate’s stock valued at $14,102,000 after acquiring an additional 1,749 shares during the period. First Interstate Bank grew its position in shares of UnitedHealth Group by 4.4% during the 3rd quarter. First Interstate Bank now owns 50,976 shares of the healthcare conglomerate’s stock valued at $9,984,000 after acquiring an additional 2,128 shares during the period. Wasatch Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $228,000. Finally, Brighton Jones LLC grew its position in shares of UnitedHealth Group by 320.7% during the 3rd quarter. Brighton Jones LLC now owns 12,357 shares of the healthcare conglomerate’s stock valued at $2,420,000 after acquiring an additional 9,420 shares during the period. 86.11% of the stock is currently owned by institutional investors.

UnitedHealth Group Inc (NYSE:UNH) opened at $243.56 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 12 month low of $156.49 and a 12 month high of $244.35. The firm has a market cap of $235,490.00, a P/E ratio of 22.74, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period last year, the company posted $2.11 EPS. The business’s revenue was up 9.5% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Inc will post 12.52 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the completion of the transaction, the director now directly owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Insiders sold a total of 33,853 shares of company stock worth $7,517,108 over the last three months. Corporate insiders own 0.89% of the company’s stock.

A number of equities research analysts have recently commented on UNH shares. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Cantor Fitzgerald restated a “buy” rating and set a $225.00 target price on shares of UnitedHealth Group in a research report on Monday, November 27th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Piper Jaffray Companies raised their target price on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research report on Tuesday, October 17th. Finally, Jefferies Group restated a “buy” rating and set a $248.00 target price on shares of UnitedHealth Group in a research report on Friday, December 1st. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $243.22.

COPYRIGHT VIOLATION NOTICE: “Norinchukin Bank The Has $35.41 Million Holdings in UnitedHealth Group Inc (UNH)” was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://theolympiareport.com/2018/01/23/norinchukin-bank-the-has-35-41-million-holdings-in-unitedhealth-group-inc-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.